US Patent 8268325 Modified Vaccinia Ankara virus variant

Patent 8268325 was granted and assigned to Bavarian Nordic A/S on September, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

82683250

Patent Inventor Names

Paul Chaplin0

Christine Meisinger-Henschel0

Paul Howley0

Date of Patent

September 18, 2012

Patent Application Number

130533610

Date Filed

March 22, 2011

Patent Citations Received

‌

US Patent 11834718 Compositions and methods for diagnosing, evaluating and treating cancer by means of the DNA methylation status

‌

US Patent 11939637 Molecular biomarkers for cancer immunotherapy

Patent Primary Examiner

‌

Benjamin P Blumel

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8268325 Modified Vaccinia Ankara virus variant

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API